The US cold and flu supplements market is anticipated to grow at a CAGR of 6.1% during the forecast period (2020-2026). The US has the highest rate of cold and flu cases in between fall and winter. According to the Center for Disease Prevention (CDC), between October 2019 and April 2020, the flu has resulted in a total of 39 million to 56 million illnesses with 24,000 to 62,000 total mortalities. In addition to these 410,000 to 740,000 patients were also hospitalized during the period of flu. Therefore, a high incidence rate of cold and flu across the region is anticipated to significantly drive the adoption of supplements for the treatment and prevention of cold and flu during the forecast period.
Browse the full report description of "US Cold and Flu Supplements Market Size, Share & Trends Analysis Report by Product Type (Natural Molecules, Herbal Extracts, and Vitamins & Minerals), and Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/us-cold-and-flu-supplements-market
Furthermore, the increasing focus towards the prevention of cold and flu is considerably high across the country. This, in turn, is driving the use of various vitamins and minerals that are safe to use on a daily basis and also increases immunity. This is also expected to impact the growth of the cold and flu supplements market across the country. Moreover, natural and vegan supplements are also gaining significant popularity across the country as the trend of turning into vegan is high in the US.
Market Coverage
o By Product Type
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected segment
US Cold and Flu Supplements Market Report Segment
By Product Type